生存分析第四部分：生存分析中的进一步概念与方法。 - Suppr

Suppr

超能文献

Survival analysis part IV: further concepts and methods in survival analysis.

作者信息

Clark T G, Bradburn M J, Love S B, Altman D G

机构信息

Cancer Research UK/NHS Centre for Statistics in Medicine, Institute of Health Sciences, Old Road, Oxford OX3 7LF, UK.

出版信息

Br J Cancer. 2003 Sep 1;89(5):781-6. doi: 10.1038/sj.bjc.6601117.

DOI:10.1038/sj.bjc.6601117

PMID:12942105

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2394469/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7b84/2394469/63c132acb59f/89-6601117f1.jpg

相似文献

Survival analysis part IV: further concepts and methods in survival analysis.

Br J Cancer. 2003 Sep 1;89(5):781-6. doi: 10.1038/sj.bjc.6601117.

Continuous and discrete time survival analysis: neural network approaches.

Annu Int Conf IEEE Eng Med Biol Soc. 2007;2007:5420-3. doi: 10.1109/IEMBS.2007.4353568.

Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit.

Br J Cancer. 2003 Aug 18;89(4):605-11. doi: 10.1038/sj.bjc.6601120.

[Clinical trials--what is the question?].

Med Klin (Munich). 1999 Apr 15;94 Suppl 2:14-6. doi: 10.1007/BF03042020.

Survival analysis part II: multivariate data analysis--an introduction to concepts and methods.

Br J Cancer. 2003 Aug 4;89(3):431-6. doi: 10.1038/sj.bjc.6601119.

Efron-type measures of prediction error for survival analysis.

Biometrics. 2007 Dec;63(4):1283-7. doi: 10.1111/j.1541-0420.2007.00832.x. Epub 2007 Jul 25.

Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach.

Stat Med. 1998 May 30;17(10):1169-86. doi: 10.1002/(sici)1097-0258(19980530)17:10<1169::aid-sim796>3.0.co;2-d.

A proposed approach for analyzing post-study therapy effect in survival analysis.

J Biopharm Stat. 2016;26(4):790-800. doi: 10.1080/10543406.2015.1074916. Epub 2015 Aug 6.

Clinical Trials, End Points, and Statistics-Measuring and Comparing Cancer Treatments in Practice.

JAMA Oncol. 2018 Dec 1;4(12):1798. doi: 10.1001/jamaoncol.2018.3708.

The what, why and how of Bayesian clinical trials monitoring.

Stat Med. 1994;13(13-14):1371-83; discussion 1385-9. doi: 10.1002/sim.4780131312.

引用本文的文献

Identifying and characterizing commercially insured patients with HFpEF with high vs low health care resource utilization.

J Manag Care Spec Pharm. 2025 Aug;31(8):741-751. doi: 10.18553/jmcp.2025.31.8.741.

Data-driven prior elicitation for Bayes factors in Cox regression for nine subfields in biomedicine.

PLoS One. 2025 May 23;20(5):e0322144. doi: 10.1371/journal.pone.0322144. eCollection 2025.

Wheezing on admission: a marker for bronchiolitis severity and asthma development.

Pediatr Res. 2025 May 3. doi: 10.1038/s41390-025-04096-9.

Predictors of relapse after discontinuing antipsychotics in patients with schizophrenia spectrum disorders.

Schizophrenia (Heidelb). 2025 Mar 13;11(1):42. doi: 10.1038/s41537-025-00592-3.

Concurrent symptom domains and associations with recovery timelines among collegiate athletes with sport-related concussion.

Br J Sports Med. 2025 Mar 25;59(7):461-469. doi: 10.1136/bjsports-2024-108351.

Accounting for Liver Transplant in Acute Liver Failure Research.

Gastro Hep Adv. 2022 Apr 29;1(4):538-545. doi: 10.1016/j.gastha.2022.02.026. eCollection 2022.

Associations of Sex and Sport Contact-Level with Recovery Timelines Among Collegiate Athletes with Sport-Related Concussion.

Sports Med Open. 2024 Jul 29;10(1):86. doi: 10.1186/s40798-024-00742-4.

Tutorial on survival modeling with applications to omics data.

Bioinformatics. 2024 Mar 4;40(3). doi: 10.1093/bioinformatics/btae132.

Odour discrimination and identification as a biomarker of long-term disability worsening in multiple sclerosis.

Mult Scler. 2024 Jan;30(1):55-62. doi: 10.1177/13524585231201093. Epub 2023 Oct 18.

HoTDAM! An easy-to-use automated assay expands the inducible thermotolerance phenotype in Drosophila melanogaster: Heat hardening reduces motility.

Comp Biochem Physiol A Mol Integr Physiol. 2023 Dec;286:111522. doi: 10.1016/j.cbpa.2023.111522. Epub 2023 Sep 23.

本文引用的文献

Survival analysis Part III: multivariate data analysis -- choosing a model and assessing its adequacy and fit.

Br J Cancer. 2003 Aug 18;89(4):605-11. doi: 10.1038/sj.bjc.6601120.

Survival analysis part II: multivariate data analysis--an introduction to concepts and methods.

Br J Cancer. 2003 Aug 4;89(3):431-6. doi: 10.1038/sj.bjc.6601119.

Survival analysis part I: basic concepts and first analyses.

Br J Cancer. 2003 Jul 21;89(2):232-8. doi: 10.1038/sj.bjc.6601118.

Developing a prognostic model in the presence of missing data: an ovarian cancer case study.

J Clin Epidemiol. 2003 Jan;56(1):28-37. doi: 10.1016/s0895-4356(02)00539-5.

Nicotine replacement therapy for smoking cessation.

Cochrane Database Syst Rev. 2002(4):CD000146. doi: 10.1002/14651858.CD000146.

Proportional hazards models with frailties and random effects.

Stat Med. 2002 Nov 15;21(21):3219-33. doi: 10.1002/sim.1259.

Proportional hazards models with random effects to examine centre effects in multicentre cancer clinical trials.

Stat Methods Med Res. 2002 Jun;11(3):221-36. doi: 10.1191/0962280202sm284ra.

Quantification of the completeness of follow-up.

Lancet. 2002 Apr 13;359(9314):1309-10. doi: 10.1016/s0140-6736(02)08272-7.

A prognostic model for ovarian cancer.

Br J Cancer. 2001 Sep 28;85(7):944-52. doi: 10.1054/bjoc.2001.2030.

Inference in randomized studies with informative censoring and discrete time-to-event endpoints.

Biometrics. 2001 Jun;57(2):404-13. doi: 10.1111/j.0006-341x.2001.00404.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验